Effect of anti-TNF- Effect of anti-TNF- Effect of anti-TNF- Effect of anti-TNF- Effect of anti-TNF- a on peritoneal endometrial implants of rats
OA: closed
CC0
AI-generated summary
This study found that while anti-TNF-alpha therapy reduced TNF-alpha expression in rat peritoneal endometrial implants, it did not decrease implant size, unlike leuprolide treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective: To evaluate the effect of anti-TNF- a in the treatment of endometrial implants in the peritoneum of rats. Methods: Endometrial implants were surgically induced in 120 female Wistar-Albino rats. The animals were randomly divided into four groups. Group C (n = 36) received an intraperitone al injection of 0.2 ml of saline. Group L (n = 41) received a subcutaneous injection of 1mg/kg of leuprolide. Group I5 (n = 20) received a subcutaneous injection of 5mg/kg of monoclonal anti-tumor necrosis factor (TNF) a (infliximab). Group I10 (n = 20) received a subcutaneous injection of 10mg/kg of infliximab. The rats were sacrificed after 21 days to assess the size of the implants and the expression of TNF. Results: Treatment with leuprolide (group L) promoted an absolute reduction in the surface area of the implant when compared with group C (+14 mm vs. 0mm, p = 0.013) and group I10 (+14 mm vs. +5 Mm, p = 0.018). Likewise, a percentage reduction of surface area of the implant was observed comparing group L with group C (+33.3% vs. 0%, p = 0.005) and group I10 (+33.3% vs. +18.3%, p = 0.027). Treatment with infliximab was not able to decrease the surface area of the implants when compared with group C. The expression of TNF- a in groups L, I5 and I10 was lower than in group C (505.6 mm 2 vs. 660.5 mm 2 vs. 317.2 mm 2 vs. 2519.3 mm 2 , respectively; p <0.001). Conclusion: The anti-TNF-a therapy reduced the expression of TNF- a in endometriotic implants, but did not reduce the surface area of the lesion.
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (35)
- Altered expression of interleukin-18 in the peritoneal fluid of women with endometriosis via openalex
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Animal studies in endometriosis: a review via openalex
- Anti-TNF-α treatment for pelvic pain associated with endometriosis via openalex
- Correlation between symptoms of pain and peritoneal fluid inflammatory cytokine concentrations in endometriosis via openalex
- Current pharmacotherapy for endometriosis via openalex
- Development of an experimental model of endometriosis in rats via openalex
- Effect of anti-TNF-α on peritoneal endometrial implants of rats via openalex
- Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system via openalex
- Effects of anti-TNF-mAb treatment on pregnancy in baboons with induced endometriosis via openalex
- Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons via openalex
- Endometriosis is sustained by tumour necrosis factor-alpha via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- [Expression of tumor necrosis factor-alpha (TNF-alpha) on peritoneal fluid mononuclear cells in women with endometriosis] via openalex
- Future directions in endometriosis research via openalex
- High-dose atorvastatin causes regression of endometriotic implants: a rat model via openalex
- Immunobiology of endometriosis via openalex
- Immunology and endometriosis via openalex
- Medical treatment for rectovaginal endometriosis: what is the evidence? via openalex
- Ovulation suppression for endometriosis via openalex
- Potential involvement of the immune system in the development of endometriosis via openalex
- Recombinant human TNFRSF1A (r-hTBP1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study via openalex
- Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib via openalex
- Role of cytokines in endometriosis via openalex
- The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat via openalex
- Tumor necrosis factor alpha secretion by peritoneal macrophages in patients with endometriosis via openalex
- Tumour necrosis factor-alpha blockers: potential limitations in the management of advanced endometriosis? A case report via openalex
- W2418200982 via openalex
- W1971586374 via openalex
- W2042642675 via openalex
- W2087810003 via openalex
- W2096980318 via openalex
- W2279547604 via openalex
- W2346020725 via openalex
- W78470307 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK